ACR Appropriateness Criteria ® on External Beam Radiation Therapy Treatment Planning for Clinically Localized Prostate Cancer. Expert Panel on Radiation Oncology-Prostate

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 3, 2009, Pages 667-672

  Michalski, Jeff M ^a   Roach III, Mack ^b   Merrick, Gregory ^c   Anscher, Mitchell S ^d   Beyer, David C ^e   Lawton, Colleen A ^f   Lee, W Robert ^g   Pollack, Alan ^h   Rosenthal, Seth A ⁱ   Vijayakumar, Srinivasan ^j   Carroll, Peter R ^b,k  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WHEELING HOSPITAL   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e Arizona Oncology Services   (United States)

^f Medical College of Wisconsin Milwaukee   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h FOX CHASE CANCER CENTER   (United States)

ⁱ Radiation Association of Sacrament   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k American Urological Association   (United States)

more..

Author keywords

Appropriateness criteria; Conformal radiotherapy; Dose escalation; External beam radiotherapy; Prostate cancer

Indexed keywords

CANCER LOCALIZATION; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTON THERAPY; RADIATION DOSE; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING; TUMOR VOLUME; URETHROGRAPHY;

CATHETERIZATION; HUMANS; IMMOBILIZATION; MALE; PROSTATE; PROSTATIC NEOPLASMS; RADIATION ONCOLOGY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; SOCIETIES, MEDICAL; TUMOR BURDEN; UNITED STATES; URETHRA;

EID: 67049172698     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.12.073     Document Type: Review

References (65)

1. Kupelian P.A., Potters L., Khuntia D., et al. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 58 (2004) 25-33
2. Kneebone A., Gebski V., Hogendoorn N., et al. A randomized trial evaluating rigid immobilization for pelvic irradiation. Int J Radiat Oncol Biol Phys 56 (2003) 1105-1111
3. Rosenthal S.A., Roach III M., Goldsmith B.J., et al. Immobilization improves the reproducibility of patient positioning during six-field conformal radiation therapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 27 (1993) 921-926
4. International Commission on Radiation Units and Measurements. ICRU report 50: Prescribing, recording, and reporting photon beam therapy (1993), International Commission on Radiation Units and Measurements, Bethesda
5. International Commission on Radiation Units and Measurements. ICRU report 62: Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50) (1999), International Commission on Radiation Units and Measurements, Bethesda
6. Malone S., Donker R., Broader M., et al. Effects of urethrography on prostate position: Considerations for radiotherapy treatment planning of prostate carcinoma. Int J Radiat Oncol Biol Phys 46 (2000) 89-93
7. Sandler H.M., Bree R.L., McLaughlin P.W., et al. Localization of the prostatic apex for radiation therapy using implanted markers. Int J Radiat Oncol Biol Phys 27 (1993) 915-919
8. Kagawa K., Lee W.R., Schultheiss T.E., et al. Initial clinical assessment of CT-MRI image fusion software in localization of the prostate for 3D conformal radiation therapy. Int J Radiat Oncol Biol Phys 38 (1997) 319-325
9. Roach III M., Holland J., Chan A., et al. Markers, CTs, urethrograms, and the prostatic apex. Int J Radiat Oncol Biol Phys 31 (1995) 207-209
10. Mah D., Freedman G., Movsas B., et al. To move or not to move: Measurements of prostate motion by urethrography using MRI. Int J Radiat Oncol Biol Phys 50 (2001) 947-951
11. Wilder R.B., Fone P.D., Rademacher D.E., et al. Localization of the prostatic apex for radiotherapy treatment planning using urethroscopy. Int J Radiat Oncol Biol Phys 38 (1997) 737-741
12. Rasch C., Barillot I., Remeijer P., et al. Definition of the prostate in CT and MRI: A multi-observer study. Int J Radiat Oncol Biol Phys 43 (1999) 57-66
13. Roach III M., Faillace-Akazawa P., Malfatti C., et al. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 35 (1996) 1011-1018
14. Crook J.M., Raymond Y., Salhani D., et al. Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol 37 (1995) 35-42
15. Milosevic M., Voruganti S., Blend R., et al. Magnetic resonance imaging (MRI) for localization of the prostatic apex: Comparison to computed tomography (CT) and urethrography. Radiother Oncol 47 (1998) 277-284
16. Buyyounouski M.K., Horwitz E.M., Price R.A., et al. Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatment. Int J Radiat Oncol Biol Phys 58 (2004) 743-749
17. McLaughlin P.W., Troyer S., Berri S., et al. Functional anatomy of the prostate: Implications for treatment planning. Int J Radiat Oncol Biol Phys 63 (2005) 479-491
18. McLaughlin P.W., Narayana V., Meirovitz A., et al. Vessel-sparing prostate radiotherapy: Dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI. Int J Radiat Oncol Biol Phys 61 (2005) 20-31
19. Steenbakkers R.J., Deurloo K.E., Nowak P.J., et al. Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate. Int J Radiat Oncol Biol Phys 57 (2003) 1269-1279
20. Davis B.J., Pisansky T.M., Wilson T.M., et al. The radial distance of extraprostatic extension of prostate carcinoma: Implications for prostate brachytherapy. Cancer 85 (1999) 2630-2637
21. Sohayda C., Kupelian P.A., Levin H.S., et al. Extent of extracapsular extension in localized prostate cancer. Urology 55 (2000) 382-386
22. Teh B.S., Bastasch M.D., Mai W.Y., et al. Predictors of extracapsular extension and its radial distance in prostate cancer: Implications for prostate IMRT, brachytherapy, and surgery. Cancer J 9 (2003) 454-460
23. Langen K.M., and Jones D.T. Organ motion and its management. Int J Radiat Oncol Biol Phys 50 (2001) 265-278
24. Antolak J.A., Rosen I.I., Childress C.H., et al. Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys 42 (1998) 661-672
25. van Herk M., Bruce A., Kroes A.P., et al. Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys 33 (1995) 1311-1320
26. Zelefsky M.J., Crean D., Mageras G.S., et al. Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. Radiother Oncol 50 (1999) 225-234
27. Gildersleve J., Dearnaley D.P., Evans P.M., et al. A randomised trial of patient repositioning during radiotherapy using a megavoltage imaging system. Radiother Oncol 31 (1994) 161-168
28. el-Gayed A.A., Bel A., Vijlbrief R., et al. Time trend of patient setup deviations during pelvic irradiation using electronic portal imaging. Radiother Oncol 26 (1993) 162-171
29. Balter J.M., Wright J.N., Newell L.J., et al. Accuracy of a wireless localization system for radiotherapy. Int J Radiat Oncol Biol Phys 61 (2005) 933-937
30. Lattanzi J., McNeeley S., Pinover W., et al. A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer. Int J Radiat Oncol Biol Phys 43 (1999) 719-725
31. Artignan X., Smitsmans M.H., Lebesque J.V., et al. Online ultrasound image guidance for radiotherapy of prostate cancer: Impact of image acquisition on prostate displacement. Int J Radiat Oncol Biol Phys 59 (2004) 595-601
32. Scarbrough T.J., Golden N.M., Ting J.Y., et al. Comparison of ultrasound and implanted seed marker prostate localization methods: Implications for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 65 (2006) 378-387
33. Court L.E., Dong L., Lee A.K., et al. An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancer. Int J Radiat Oncol Biol Phys 62 (2005) 154-163
34. Teh B.S., McGary J.E., Dong L., et al. The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: More than just a prostate gland immobilization device?. Cancer J 8 (2002) 476-483
35. Teh B.S., Dong L., McGary J.E., et al. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity modulated radiotherapy (IMRT) for prostate cancer. Med Dosim 30 (2005) 25-30
36. Fiorino C., Reni M., Cattaneo G.M., et al. Comparing 3-, 4- and 6-fields techniques for conformal irradiation of prostate and seminal vesicles using dose-volume histograms. Radiother Oncol 44 (1997) 251-257
37. Michalski J.M., Purdy J.A., Winter K., et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys 46 (2000) 391-402
38. Michalski J.M., Winter K., Purdy J.A., et al. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose level V. Int J Radiat Oncol Biol Phys 62 (2005) 706-713
39. Michalski J.M., Winter K., Purdy J.A., et al. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV. Int J Radiat Oncol Biol Phys 58 (2004) 735-742
40. Ryu J.K., Winter K., and Michalski J.M. Preliminary report of toxicity following 3D conformal radiation therapy (3DCRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). Int J Radiat Oncol Biol Phys 51 (2001) 136-137
41. Ten Haken R.K., Perez-Tamayo C., Tesser R.J., et al. Boost treatment of the prostate using shaped, fixed fields. Int J Radiat Oncol Biol Phys 16 (1989) 193-200
42. Dearnaley D.P., Khoo V.S., Norman A.R., et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 353 (1999) 267-272
43. Koper P.C., Stroom J.C., van Putten W.L., et al. Acute morbidity reduction using 3DCRT for prostate carcinoma: A randomized study. Int J Radiat Oncol Biol Phys 43 (1999) 727-734
44. Storey M.R., Pollack A., Zagars G., et al. Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 48 (2000) 635-642
45. Ling C.C., Burman C., Chui C.S., et al. Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys 35 (1996) 721-730
46. Pickett B., Vigneault E., Kurhanewicz J., et al. Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 44 (1999) 921-929
47. Zelefsky M.J., Fuks Z., Happersett L., et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 55 (2000) 241-249
48. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969-974
49. Hurwitz M.D., Schnieder L., Manola J., et al. Lack of radiation dose response for patients with low-risk clinically localized prostate cancer: A retrospective analysis. Int J Radiat Oncol Biol Phys 53 (2002) 1106-1110
50. Pollack A., Hanlon A.L., Horwitz E.M., et al. Prostate cancer radiotherapy dose response: An update of the Fox Chase experience. J Urol 171 (2004) 1132-1136
51. Symon Z., Griffith K.A., McLaughlin P.W., et al. Dose escalation for localized prostate cancer: Substantial benefit observed with 3D conformal therapy. Int J Radiat Oncol Biol Phys 57 (2003) 384-3890
52. Pollack A., Smith L.G., and von Eschenbach A.C. External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era. Int J Radiat Oncol Biol Phys 48 (2000) 507-512
53. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 166 (2001) 876-881
54. Khuntia D., Reddy C.A., Mahadevan A., et al. Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: What should we expect?. Cancer 100 (2004) 1283-1292
55. Cheung R., Tucker S.L., Dong L., et al. Dose-response for biochemical control among high-risk prostate cancer patients after external beam radiotherapy. Int J Radiat Oncol Biol Phys 56 (2003) 1234-1240
56. Dearnaley D.P., Sydes M.R., Graham J.D., et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial. Lancet Oncol 8 (2007) 475-487
57. Kuban D.A., Tucker S.L., Dong L., et al. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70 (2008) 67-74
58. Peeters S.T., Heemsbergen W.D., Koper P.C., et al. Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24 (2006) 1990-1996
59. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
60. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA 294 (2005) 1233-1239
61. Nguyen L.N., Pollack A., and Zagars G.K. Late effects after radiotherapy for prostate cancer in a randomized dose-response study: Results of a self-assessment questionnaire. Urology 51 (1998) 991-997
62. Michalski J.M., Winter K., Purdy J.A., et al. Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406. Semin Radiat Oncol 12 (2002) 75-80
63. Boersma L.J., van den Brink M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 41 (1998) 83-92
64. Jackson A., Skwarchuk M.W., Zelefsky M.J., et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 49 (2001) 685-698
65. Huang E.H., Pollack A., Levy L., et al. Late rectal toxicity: Dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 54 (2002) 1314-1321